Novartis to pay $100m upfront to Voyager for gene therapies
HQ Team January 3, 2023: Voyager Therapeutics, Inc., will receive an upfront payment of $100 million from Switzerland-based Novartis AG to develop gene.
Drugs
Health
Pharma